Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor

MLA

Baojin Wang, et al. “Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor.” Molecular Cancer Therapeutics, vol. 18, no. 12, Dec. 2019, pp. 2233–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....04266049ed8908a7522ed99c0679e5ce&authtype=sso&custid=ns315887.

APA

Baojin Wang, Zhongzhi Wu, Xinchun Tian, Hidemichi Watari, Lawrence M. Pfeffer, Wei Li, Huan Yan, Guannan Zhao, Yuqi Guo, Junming Yue, Peixin Dong, & Qinghui Wang. (2019). Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor. Molecular Cancer Therapeutics, 18(12), 2233–2245.

Chicago

Baojin Wang, Zhongzhi Wu, Xinchun Tian, Hidemichi Watari, Lawrence M. Pfeffer, Wei Li, Huan Yan, et al. 2019. “Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor.” Molecular Cancer Therapeutics 18 (12): 2233–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....04266049ed8908a7522ed99c0679e5ce&authtype=sso&custid=ns315887.